Stock listing
JSPR Stock Price, News, Filings & Events — Jasper Therapeutics, Inc.
Selected listing: JSPR · NASDAQ · USD · US
This page tracks Jasper Therapeutics, Inc.'s JSPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JSPR:NASDAQ. JSPR:NASDAQ is the stock-level entry point for investors researching Jasper Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jasper Therapeutics, Inc. is a public company traded under the ticker JSPR in the American market. The company has a market capitalization of approximately $24.79 million. Jasper Therapeutics focuses on developing innovative therapies in the biotechnology sector.
- Ticker
- JSPR:NASDAQ
- Asset type
- Stock
- Market cap
- $22.0M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Jasper Therapeutics, Inc. JSPR:NASDAQ stock context
This page tracks Jasper Therapeutics, Inc.'s JSPR:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following JSPR:NASDAQ. JSPR:NASDAQ is the stock-level entry point for investors researching Jasper Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Jasper Therapeutics, Inc. is a public company traded under the ticker JSPR in the American market. The company has a market capitalization of approximately $24.79 million. Jasper Therapeutics focuses on developing innovative therapies in the biotechnology sector.
Latest news from Jasper Therapeutics, Inc.
Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 17, 2026
Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
June 1, 2026
Jasper Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
March 30, 2026
Research Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for JSPR:NASDAQ.
Jasper Therapeutics, Inc. company profile
View the public company page for Jasper Therapeutics, Inc. on 6ix.
Jasper Therapeutics, Inc. news
Read company news and market updates connected to Jasper Therapeutics, Inc..
Jasper Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Jasper Therapeutics, Inc..